Text Size

Ocular hypotensive effect of tafluprost in latanoprost low-responder cynomolgus monkeys

Kurashima H., Asai Y., Aihara M., Ishida N., Nakamura M., Araie M.


  • 2012
  • Journal of Glaucoma
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Preclinical development

  • Affiliations

    Research and Development Center, Santen Pharmaceutical Co., Ltd, Nara, Japan; Graduate School of Biological Sciences, Nara Institute of Science and Technology, Nara, Japan; Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan

Related Publications

24-Hour Evaluation of the Effectiveness and Tolerability of Preservative-Free Tafluprost-Timolol Fixed Combination in Open-Angle Glaucoma or Ocular Hypertensive Patients Previously Treated with Preserved Latanoprost

Oddone F, Tanga L, Giammaria S, Sabbatini L, Strianese A, Ferrazza M, Rossetti LM


MicroRNA profile of extracellular vesicles released by Müller glial cells

Lamb W D.B.; Eastlake K.; Luis J.; Sharif N.A. ; Khaw P. T.; Limb G. A.


Steroid-Induced Ocular Hypertension in Mice Is Differentially Reduced by Selective EP2, EP3, EP4, and IP Prostanoid Receptor Agonists

Sharif N.A.; Millar J.C.; Zode G.; Ota T.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022